Repurposing Donepezil to Treat COVID-19: A Call for Retrospective Analysis of Existing Patient Datasets
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 3
Abstract
We hypothesize that patients treated with donepezil will show decreased risk of death following COVID-19 infection. The acetylcholinesterase antagonist donepezil is widely prescribed for early-stage Alzheimer’s disease. Clinical studies show donepezil treatment decreases risk of death from pneumonia and myocardial infarct, improves vascular function and inhibits risk of stroke. Preclinical studies indicate donepezil itself or increased acetylcholine more generally protect from fatal Acute Respiratory Distress Syndrome (ARDS), sepsis, cytokine storm, cardiovascular damage, Disseminated Intravascular Coagulation (DIC) and acute kidney damage. Donepezil is also an agonist of the anti-viral sigma-1 receptor. In the United States, there have been over 600,000 confirmed cases of COVID-19 infection and over 170,000 deaths associated with nursing home outbreaks. Rather than run a new clinical trial, our hypothesis can be tested through retrospective analysis of data obtained from nursing home or hospital databases collected at the county, state, or federal level. We believe retrospective analysis of this data will show donepezil treatment shortens hospital stay decreases overall risk of hospitalization and death. The data could be rapidly translated into clinical practice to prevent COVID-19 fatalities in the most vulnerable patient populations.
Authors and Affiliations
Meena M Murali, Joy A Phillips*
Keywords
Related Articles
- EP ID EP699109
- DOI http://dx.doi.org/10.46889/JCIM.2021.2305
- Views 131
- Downloads 0
Leucocytes and CD4 Counts of Petrol Attendants in Ekpoma, Edo State, Nigeria
hite Blood Cells (WBCs), also called leucocytes or leukocytes, are the cells of the immune system that are involved in protecting the body against both infectious diseases and foreign invaders. The overall aim of this st...
Immuno-Multi-Therapy and Prophylaxis Efficacy against COVID-19
In the context of the current COVID-19 pandemic, strategies for finding effective therapies advocate the so-called "therapeutic repositioning" approach, i.e., the use of existing molecules on the pharmaceutical market,...
Water In the Body - The Harm of Drinking Ice Water and Ice Drinks
Drinking water is very important because our body is mostly water – a fetus is 95% water, a baby is 92% water – that is why they grow so fast. Between ages 20 and 30, the water content in the body drops to 70%. Between...
Extracellular Vesicles: Role in Disease Biology
Membrane-enclosed structures known as Extracellular Vesicles (EVs) are effective for conducting intercellular connection. They are diverse and include apoptotic bodies, micro vesicles and exosomes. Vascular Endothelial C...
Ab Initio Whole Cell Kinetic Model of Lactobacillus acidophilus NCFM (lacAS24)
Lactobacillus acidophilus is a commonly used probiotic that offers numerous health benefits in the human gut, particularly in addressing various disorders. L. acidophilus North Carolina Food Microbiology (NCFM), a specif...